NAT2 - N-acetyltransferase 2 Gene
Also Known as AAC2; PNAT; NAT-2
Species: Homo sapiens
About NAT2
This gene has 2 transcripts (splice variants), 303 orthologues, 1 paralogue and is associated with 1 phenotype. Biased expression in liver (RPKM 16.4), duodenum (RPKM 11.9) and 2 other tissues.
Summary
This gene encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are responsible for the N-acetylation polymorphism in which human populations segregate into rapid, intermediate, and slow acetylator phenotypes. Polymorphisms in this gene are also associated with higher incidences of Cancer and drug toxicity. A second polymorphic arylamine N-acetyltransferase gene (NAT1), is located near this gene (NAT2). [provided by RefSeq, Sep 2019]
NAT2 Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_000015.3 | NP_000006.2 | arylamine N-acetyltransferase 2 |
| NM_000015.3 | NP_000006.2 | arylamine N-acetyltransferase 2 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables N-hydroxyarylamine O-acetyltransferase activity |
IDA
IDA: Inferred from direct assay
|
7915226 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
25640309 | GOA |
NAT2 Protein Structure
Acetyltransf_2: N-acetyltransferase (20 - 279)
- 0
- 100
- 200
- 290 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
arylamine N-acetyltransferase 2 |
|
NAT2 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
NAT2 | P11245 | RAD51 | Homo sapiens | Q06609 | 25640309 | |
|
Intra
|
NAT2 | P11245 | RAD51 | Homo sapiens | Q06609 | 25640309 | |
|
Intra
|
NAT2 | P11245 | ATM | Homo sapiens | Q13315 | 25640309 | |
|
Intra
|
NAT2 | P11245 | ATM | Homo sapiens | Q13315 | 25640309 | |
|
Intra
|
NAT2 | P11245 | MBD4 | Homo sapiens | O95243-2 | 32296183 | |
|
Intra
|
NAT2 | P11245 | MBD4 | Homo sapiens | O95243-2 | 32296183 |
NAT2 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P811309 | NAT-2 Antibody | WB, IHC-P | Human, Mouse, Rat |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Acetylation, Slow |
|
|
| Multiple Chemical Sensitivity |
|
|
| 1,4-Phenylenediamine Allergic Contact Dermatitis |
|
|
| Oral Tuberculosis |
|
|
| Allergic Contact Dermatitis |
|
|
| Drug-Induced Hepatitis |
|
|
| Pulmonary Tuberculosis |
|
|
| Methemoglobinemia |
|
|
| Trimethoprim Allergy |
|
|
| Bladder Cancer |
|
|
| Neural Tube Defects |
|
|
| Gilbert Syndrome |
|
|
| Drug-Induced Lupus Erythematosus |
|
|
| Mycobacterium Tuberculosis 1 |
|
|
| Deafness, Autosomal Dominant 18 |
|
|
| Squamous Cell Carcinoma |
|
|
| Alcoholic Pancreatitis |
|
|
| Endometriosis |
|
|
| Transitional Cell Carcinoma |
|
|
| Gastroschisis |
|
|
| Laryngeal Squamous Cell Carcinoma |
|
|
| Colorectal Cancer |
|
|
| Breast Cancer |
|
|
| Multidrug-Resistant Tuberculosis |
|
|
| Cholangiocarcinoma |
|
|
| Clubfoot |
|
|
| Parkinson Disease, Late-Onset |
|
|
| Cataract |
|
|
| Lung Cancer |
|
|
| Inflammatory Bowel Disease |
|
|
| Granulocytopenia |
|
|
| Cystic Fibrosis |
|
|
| Diabetes Mellitus |
|
|
| Systemic Lupus Erythematosus |
|
|
| Motor Neuron Disease |
|
|
| Behcet Syndrome |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Macaca mulatta | NAT2 | VGNC | VGNC:84092 |
| Rattus norvegicus | NAT2 | RGD | RGD:70492 |